Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion
Wang, Jing, Pursell, Natalie W, Samson, Maria Elena S, Atoyan, Ruzanna, Ma, Anna W, Selmi, Abdelkader, Xu, Wanlu, Cai, Xiong, Voi, Maurizio, Savagner, Pierre, Lai, Cheng-Jung
Published in Molecular cancer therapeutics (01.06.2013)
Published in Molecular cancer therapeutics (01.06.2013)
Get full text
Journal Article
Hepatocyte mARC1 promotes fatty liver disease
Lewis, Lara C., Chen, Lingyan, Hameed, L. Shahul, Kitchen, Robert R., Maroteau, Cyrielle, Nagarajan, Shilpa R., Norlin, Jenny, Daly, Charlotte E., Szczerbinska, Iwona, Hjuler, Sara Toftegaard, Patel, Rahul, Livingstone, Eilidh J., Durrant, Tom N., Wondimu, Elisabeth, BasuRay, Soumik, Chandran, Anandhakumar, Lee, Wan-Hung, Hu, Sile, Gilboa, Barak, Grandi, Megan E., Toledo, Enrique M., Erikat, Abdullah H.A., Hodson, Leanne, Haynes, William G., Pursell, Natalie W., Coppieters, Ken, Fleckner, Jan, Howson, Joanna M.M., Andersen, Birgitte, Ruby, Maxwell A.
Published in JHEP reports (01.05.2023)
Published in JHEP reports (01.05.2023)
Get full text
Journal Article